Treatment of cats with feline infectious peritonitis

详细信息	查看全文 | 推荐本文 |

• 作者：Katrin Hartmann ; Susanne Ritz
• 关键词：Feline infectious peritonitis ; Cat ; Treatment ; Review
• 刊名：Veterinary Immunology and Immunopathology
• 出版年：2008
• 期刊代码：105_01652427
• 类别：abs
• 出版时间：15 May 2008
• 卷：123
• 期：1-2
• 页码：172-175
• 文件大小：105 K

摘要

Feline infectious peritonitis (FIP) infection resulting in clinical signs is invariably fatal despite clinical intervention. As FIP is an immune-mediated disease, treatment is mainly aimed at controlling the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression but do not produce a cure. In nearly every published case report of attempted therapy for clinical FIP, glucocorticoids have been used; there are, however, no controlled studies that evaluate the effect of glucocorticoids as a therapy for FIP. Some veterinarians prescribe immune modulators to treat cats with FIP with no documented controlled evidence of efficacy. It has been suggested that these agents may benefit infected animals by restoring compromised immune function, thereby allowing the patient to control viral burden and recover from clinical signs. However, a non-specific stimulation of the immune system may be contraindicated as clinical signs develop and progress as a result of an immune-mediated response to the mutated FCoV.